INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2020

Vitamin D supplementation reduced adverse colorectal cancer outcomes by 30% in a meta-analysis of randomized controlled trials.

A systematic review and random-effects meta-analysis evaluated the effect of vitamin D supplementation on colorectal cancer (CRC) survival outcomes across RCTs. Across five included trials (n = 815), supplementation was associated with a 30% reduction in adverse CRC outcomes (HR = 0.70; 95% CI: 0.48-0.93). A beneficial effect on progression-free survival was observed in trials of patients with CRC at the outset (HR = 0.65; 95% CI: 0.36-0.94), along with a suggestive effect on CRC-specific survival in incident cases from population trials (HR = 0.76; 95% CI: 0.39-1.13). The authors noted trials varied in inclusion criteria, intervention dose, and outcomes.

Study type
Systematic review and meta-analysis of RCTs
Who was studied
Colorectal cancer cases from 7 RCTs (n = 957 total cases; n = 815 in meta-analysis)
What was measured
Colorectal cancer survival outcomes, including adverse CRC outcomes, progression-free survival, and CRC-specific survival

THE PAPER

The effect of vitamin D supplementation on survival in patients with colorectal cancer: systematic review and meta-analysis of randomised controlled trials.

Vaughan-Shaw PG, Buijs LF, Blackmur JP, Theodoratou E, Zgaga L, Din FVN, Farrington SM, Dunlop MG. Br J Cancer, 2020.

PubMed 32929196 ↗DOI 10.3322/caac.21492 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.